Analysts at SunTrust Banks Inc. began coverage on shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in a report released on Thursday. The brokerage set a “buy” rating and a $8.00 price target on the stock. SunTrust Banks Inc.’s price target would suggest a potential upside of 38.89% from the stock’s previous close.
Other analysts have also recently issued research reports about the company. B. Riley assumed coverage on Ekso Bionics Holdings in a research note on Wednesday, September 21st. They set a “buy” rating and a $8.00 price objective on the stock. Zacks Investment Research cut Ekso Bionics Holdings from a “hold” rating to a “sell” rating in a research report on Tuesday, August 2nd. Finally, Rodman & Renshaw reiterated a “buy” rating on shares of Ekso Bionics Holdings in a research report on Sunday, July 31st.
Ekso Bionics Holdings (NASDAQ:EKSO) opened at 5.76 on Thursday. Ekso Bionics Holdings has a one year low of $3.45 and a one year high of $10.08. The firm’s market capitalization is $94.65 million. The company’s 50-day moving average price is $4.42 and its 200 day moving average price is $5.40.
Ekso Bionics Holdings (NASDAQ:EKSO) last announced its quarterly earnings data on Thursday, July 28th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.28) by $0.33. On average, analysts forecast that Ekso Bionics Holdings will post ($1.74) earnings per share for the current year.